IP Library › Granted Patent US 9,725,464

Granted Patent B2

US 9,725,464 · App. 15/032,552 · Granted Aug 8, 2017

Process for preparing tetracyclic heterocycle compounds

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,725,464
App. No.: 15/032,552
Granted: Aug 8, 2017
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention is directed to a process for preparing Tetracyclic Heterocycle Compounds of formula (I): which are useful as HCV NS5A inhibitors. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).

Claims (92)

1. A process for preparing a compound of Formula I:

and pharmaceutically acceptable salts thereof,

wherein said process comprises:

(A) (i) contacting the compound of Formula VI with bis(pinacoloato)diboron in the presence of an acetate or pivalate base, a transition metal catalyst, and optionally in the presence of a phosphorus ligand source, in a mixture of water and an organic solvent E, to provide an intermediate compound of Formula VII:

then (ii) contacting the intermediate compound of formula VII with a compound of formula VIIb

in the presence of a carbonate, acetate or pivalate base and a transition metal catalyst, and optionally in the presence of a phosphorus ligand source, in said mixture of water and organic solvent E, to provide a compound of formula VIII:

wherein organic solvent E is selected from dimethylacetamide, toluene, acetonitrile, N,N-dimethylformamide, tetrahydrofuran, 2-methyl tetrahydrofuran, cyclopentyl methyl ether, isopropanol, ethanol, ethyl acetate, isopropyl acetate and dimethoxyethane; and

(B) (i) contacting the di-p-nitrobenzoate salt of the compound of Formula VIII with an inorganic base, in an organic solvent F, for a time sufficient to remove the Boc protecting groups from the compound of Formula VIII, then (ii) contacting the deprotected compound in situ with HCl to provide a compound of Formula IX:

wherein organic solvent F is selected from methanol, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran, ethanol, isopropanol and toluene; and

(C) contacting the compound of Formula IX with: (i) an additive selected from 2-hydroxypyridine-N-oxide, N-hydroxysuccinimide, HOBt and pyridine, and (ii) a non-nucleophilic base) in the presence of (i) a compound of formula Xa:

and (ii) an amide coupling reagent in an organic solvent G to provide a compound of Formula I:

wherein organic solvent G is selected from tetrahydrofuran, N,N-dimethylformamide, dimethylacetamide, N-methylpyrrolidinone and dimethylsulfoxide; and

wherein

each occurrence of R 1 is independently C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl or C 6 -C 10 aryl;

each occurrence of R 2 is independently C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, 3 to 7-membered monocyclic heterocycloalkyl or C 6 -C 10 aryl;

R 3 is C 1 -C 6 alkyl, C 3 -C 7 cycloalkyl, C 6 -C 10 aryl, 5 or 6-membered monocyclic heteroaryl or 9 or 10-membered bicyclic heteroaryl, wherein said C 3 -C 7 cycloalkyl group, said C 6 -C 10 aryl group, said 5 or 6-membered monocyclic heteroaryl group or said 9 or 10-membered bicyclic heteroaryl group can be optionally substituted with up to three groups, each independently selected from C 1 -C 6 alkyl and C 3 -C 7 cycloalkyl; and

R a is Br, Cl or I.

2. The process according to claim 1 , wherein:

Step A, part (i) is conducted at a temperature in a range of from about 40° C. to about 110° C.;

the organic solvent employed in step A, part (i) is N,N-dimethylformamide;

the acetate or pivalate base employed in Step A, part (i) is selected from NaOAc, CsOAc, KOPiv, NaOPiv and potassium acetate;

the transition metal catalyst employed in Step A, part (i) is selected from Pd 2 dba 3 , Pd(OAc) 2 and PdCl 2 ;

the optional phosphine ligand employed in Step A, part (i) is selected from N-Bu(Ad) 2 P, Am-phos, n-BuP(t-Bu) 2 -HBF 4 , XPhos, SPhos, BrettPhos, DTBPF, PCy 3 and P(t-Bu) 3 ;

Step A, part (ii) is conducted at a temperature in a range of from about 40° C. to about 110° C.;

the organic solvent employed in step A, part (ii) is N,N-dimethylformamide;

the carbonate, acetate or pivalate base employed in Step A, part (ii) is selected from K 2 CO 3 , NaOAc, CsOAc, KOPiv, NaOPiv and potassium acetate;

the transition metal catalyst employed in Step A part (ii) is selected from Pd 2 dba 3 , Pd(OAc) 2 and PdCl 2 ;

the optional phosphine ligand employed in Step A, part (ii) is selected from N-Bu(Ad) 2 P, Am-phos, n-BuP(t-Bu) 2 -HBF 4 , XPhos, SPhos, BrettPhos, DTBPF, PCy 3 and P(t-Bu) 3 ;

Step B, part (i) is conducted at a temperature in a range of from about 0° C. to about 60° C.;

the organic solvent employed in step B is N,N-dimethylformamide;

the inorganic base employed in step B is selected from a carbonate base, a phosponate base or an alkali metal hydroxide base;

Step B, part (ii) is conducted at a temperature in a range of from about 20° C. to about 60° C.;

Step C is conducted at a temperature in a range of from about −10° C. to about 60° C.;

the organic solvent employed in step C is N,N-dimethylformamide;

the non-nucleophilic base employed in step C is selected from (N-methylmorpholine, triethylamine, diisopropylethylamine and pyridine;

the amide coupling reagent employed in step C is selected from DCC, HATU, T3P and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride.

3. The process according to claim 1 , wherein each occurrence of R 1 and R 2 is independently C 1 -C 6 alkyl and R 3 is 5 or 6-membered heteroaryl or C 6 -C 10 aryl, wherein R 3 can be optionally substituted with a group selected from C 1 -C 6 alkyl and C 3 -C 7 cycloalkyl.

4. The process according to claim 1 , wherein:

Step A, part (i) is conducted at a temperature in a range of from about 70° C. to about 90° C.;

the organic solvent employed in step A, part (i) is a mixture of DME and water;

the acetate or pivalate base employed in Step A, part (i) is selected from NaOAc, CsOAc and potassium acetate;

the transition metal catalyst employed in Step A part (i) is Pd 2 dba 3 ;

the optional phosphine ligand employed in Step A, part (i) is N-Bu(Ad) 2 P;

Step A, part (ii) is conducted at a temperature in a range of from about 70° C. to about 90° C.;

the organic solvent employed in step A, part (ii) is a mixture of DME and water;

the carbonate, acetate or pivalate base employed in Step A, part (ii) is Na 2 CO 3 or K 2 CO 3 ;

the transition metal catalyst employed in Step A, part (ii) is Pd 2 dba 3 ;

the optional phosphine ligand employed in Step A, part (ii) is Am-phos;

Step B, part (i) is conducted at a temperature in a range of from about 15° C. to about 30° C.;

the organic solvent employed in step B is an organic alcohol;

the inorganic base employed in step B is an alkali metal carbonate base;

Step D, part (ii) is conducted at a temperature in a range of from about 35° C. to about 50° C.;

Step C is conducted at a temperature in a range of from about 15° C. to about 35° C.;

the organic solvent employed in step C is acetonitrile;

the additive employed in step C is HOBt;

the non-nucleophilic base employed in step C is N-methylmorpholine;

the amide coupling reagent employed in step C is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride.

5. The process according to claim 4 , wherein:

Step A, part (i) is conducted at a temperature in a range of from about 70° C. to about 90° C.;

the organic solvent employed in step A, part (i) is a mixture of DME and water;

the acetate or pivalate base employed in Step A, part (i) is selected from NaOAc, CsOAc and potassium acetate;

the transition metal catalyst employed in Step A, part (i) is Pd 2 dba 3 ;